News - Pharmacta

Why TrumpRx’s Real Test Is Pharmacy Access, Not Price

TrumpRx now lists 800+ drugs, but AMCP’s Adam Colborn says a discounted price means nothing if the local pharmacy won’t

FTC settlements with Express Scripts and CVS Caremark are forcing structural transparency into PBM operations — here’s what changes and

Employer contracts with the Big Three PBMs dropped nearly 10 points in a single year — and over half are

Eli Lilly has sued six companies and flagged 14,000+ listings globally selling black-market retatrutide — a supply chain integrity story

CSafe’s new mobile app brings real-time cold chain shipment monitoring to the warehouse floor and tarmac — no desktop required.

A fridge-free tetanus-diphtheria vaccine just cleared phase 1 trials — stable for two years at up to 30°C, with 60

India has inspected nearly 90% of its cough syrup manufacturers and taken 950+ regulatory actions — here’s what buyers sourcing

FDA’s new GDUFA IV proposal keeps the 10-month review target and adds real incentives for domestic generic drug manufacturing. The

Nearly half of biopharma companies still can’t find CDMO capacity — even as sponsors turn their own plants into contract

Three PBM-owned pharmacies control two-thirds of specialty drug dispensing revenue — here’s the full landscape access teams need to navigate.